Annual CFF:
$713.24M+$653.69M(+1097.75%)Summary
- As of today, JANX annual cash from financing is $713.24 million, with the most recent change of +$653.69 million (+1097.75%) on December 31, 2024.
- During the last 3 years, JANX annual cash from financing has risen by +$326.71 million (+84.53%).
- JANX annual cash from financing is now at all-time high.
Performance
JANX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$493.00K-$461.00K(-48.32%)Summary
- As of today, JANX quarterly cash from financing is $493.00 thousand, with the most recent change of -$461.00 thousand (-48.32%) on September 30, 2025.
- Over the past year, JANX quarterly cash from financing has dropped by -$1.16 million (-70.10%).
- JANX quarterly cash from financing is now -99.87% below its all-time high of $386.65 million, reached on December 31, 2024.
Performance
JANX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$388.65M-$1.16M(-0.30%)Summary
- As of today, JANX TTM cash from financing is $388.65 million, with the most recent change of -$1.16 million (-0.30%) on September 30, 2025.
- Over the past year, JANX TTM cash from financing has increased by +$61.23 million (+18.70%).
- JANX TTM cash from financing is now -45.51% below its all-time high of $713.24 million, reached on December 31, 2024.
Performance
JANX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JANX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1097.8% | -70.1% | +18.7% |
| 3Y3 Years | +84.5% | +100.0% | +10000.0% |
| 5Y5 Years | +10000.0% | +1593.9% | +5475.3% |
JANX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | -99.9% | >+9999.0% | -45.5% | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | -99.9% | +158.5% | -45.5% | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -99.9% | +158.5% | -45.5% | >+9999.0% |
JANX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $493.00K(-48.3%) | $388.65M(-0.3%) |
| Jun 2025 | - | $954.00K(+72.2%) | $389.81M(-0.5%) |
| Mar 2025 | - | $554.00K(-99.9%) | $391.62M(-45.1%) |
| Dec 2024 | $713.24M(+1097.7%) | $386.65M(>+9900.0%) | $713.24M(+117.8%) |
| Sep 2024 | - | $1.65M(-40.4%) | $327.42M(-14.4%) |
| Jun 2024 | - | $2.77M(-99.1%) | $382.38M(+0.6%) |
| Mar 2024 | - | $322.17M(>+9900.0%) | $380.14M(+538.4%) |
| Dec 2023 | $59.55M(>+9900.0%) | $831.00K(-98.5%) | $59.55M(+1.1%) |
| Sep 2023 | - | $56.61M(>+9900.0%) | $58.91M(+2462.3%) |
| Jun 2023 | - | $528.00K(-66.6%) | $2.30M(+10.6%) |
| Mar 2023 | - | $1.58M(+727.2%) | $2.08M(+315.8%) |
| Dec 2022 | $500.00K | $191.00K(>+9900.0%) | $500.00K(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) | $473.00K(+227.8%) |
| Jun 2022 | - | $308.00K(>+9900.0%) | -$370.00K(-100.1%) |
| Mar 2022 | - | $1000.00(-99.4%) | $328.98M(-14.9%) |
| Dec 2021 | $386.52M(+3254.1%) | $164.00K(+119.5%) | $386.52M(+0.0%) |
| Sep 2021 | - | -$843.00K(-100.3%) | $386.36M(-0.2%) |
| Jun 2021 | - | $329.66M(+472.9%) | $387.17M(+514.4%) |
| Mar 2021 | - | $57.55M(>+9900.0%) | $63.01M(+803.9%) |
| Dec 2020 | $11.52M(+188.1%) | - | - |
| Sep 2020 | - | -$33.00K(-100.6%) | $6.97M(-0.5%) |
| Jun 2020 | - | $5.50M(+265.7%) | $7.00M(+365.7%) |
| Mar 2020 | - | $1.50M | $1.50M |
| Dec 2019 | $4.00M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Janux Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Janux Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Janux Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of JANX is $713.24M
What is the all-time high annual cash from financing for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual cash from financing is $713.24M
What is Janux Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, JANX annual cash from financing has changed by +$653.69M (+1097.75%)
What is Janux Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of JANX is $493.00K
What is the all-time high quarterly cash from financing for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly cash from financing is $386.65M
What is Janux Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, JANX quarterly cash from financing has changed by -$1.16M (-70.10%)
What is Janux Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of JANX is $388.65M
What is the all-time high TTM cash from financing for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM cash from financing is $713.24M
What is Janux Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, JANX TTM cash from financing has changed by +$61.23M (+18.70%)